Ledger.Open graph →
SEC Form D · filed December 6, 2019

Black Diamond Therapeutics, Inc

Offering
$85.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David M. Epstein · Boston, MAExec · DirectorAli M. Behbahani · Stony Brook, NYDirectorGarry M. Menzel · Cambridge, MADirectorSamarth M. Kulkarni · Cambridge, MADirectorThomas M. Leggett · Cambridge, MAExecBrent M. Hatzis-Schoch · Cambridge, MAExecChristopher M. Roberts · Cambridge, MAExecRajeev M. Shah · Stony Brook, NYDirectorAlexander M. Mayweg · Cambridge, MADirectorBradley M. Bolzon · Cambridge, MADirectorDavid M. Epstein · Boston, MAExec · DirectorThomas M. Leggett · Cambridge, MAExecBrent M. Hatzis-Schoch · Cambridge, MAExecChristopher M. Roberts · Cambridge, MAExecAli M. Behbahani · Stony Brook, NYDirectorRajeev M. Shah · Stony Brook, NYDirectorGarry M. Menzel · Cambridge, MADirectorAlexander M. Mayweg · Cambridge, MADirectorBradley M. Bolzon · Stony Brook, NYDirectorSamarth M. Kulkarni · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗